{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T16:09:42Z","timestamp":1753891782491,"version":"3.41.2"},"reference-count":21,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,2,11]],"date-time":"2021-02-11T00:00:00Z","timestamp":1613001600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:p>Vascular leiomyosarcoma is an extremely rare tumor and is associated with poor prognosis among leiomyosarcoma. Surgical resection remains the main treatment option. But outcome of definitive treatment with chemoradiotherapy in inoperable patients is not clear. Here, we report treatment and outcome of definitive chemoradiotherapy in a case of vascular leiomyosarcoma. A 64-year-old man with the initial presentation of pulsatile right neck mass was diagnosed with right carotid body leiomyosarcoma. He refused surgical intervention due to risk of carotid body injury and ischemic stroke. Successful tumor control was achieved with carboplatin-based concurrent chemoradiotherapy. Investigational liquid biopsy for circulating sarcoma cells was also performed to analyze drug sensitivity profile of this rare tumor. One year after treatment, the disease remained well controlled and there was no evidence of baroreflex failure or treatment-related late toxicities. To our best knowledge, this is the first case report of right carotid body leiomyosarcoma controlled with definitive concurrent chemoradiotherapy. The approach of personalized multi-modality treatment will be a focus of our future investigation.<\/jats:p>","DOI":"10.3389\/fonc.2020.599403","type":"journal-article","created":{"date-parts":[[2021,2,13]],"date-time":"2021-02-13T16:36:01Z","timestamp":1613234161000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Chemoradiotherapy for Inoperable Carotid Body Leiomyosarcoma: A Case Report and Review of Literature"],"prefix":"10.3389","volume":"10","author":[{"given":"Cheng-Sheng","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jia-Ruey","family":"Tsai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi-Tzu","family":"Kao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Long-Sheng","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yin-Ju","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thierry","family":"Burnouf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peng-Yuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeng-Fong","family":"Chiou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lai-Lei","family":"Ting","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2021,2,11]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/2045-3329-2-14","article-title":"The epidemiology of sarcoma","volume":"2","author":"Burningham","year":"2012","journal-title":"Clin Sarcoma Res"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/j.surg.2010.10.011","article-title":"Primary leiomyosarcoma of the inferior vena cava: a 2-institution analysis of outcomes","volume":"151","author":"Mann","year":"2012","journal-title":"Surgery"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdq039","article-title":"Clinical outcome of leiomyosarcomas of vascular origin: comparison with leiomyosarcomas of other origin","volume":"21","author":"Italiano","year":"2010","journal-title":"Ann Oncol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/S0360-3016(00)00753-7","article-title":"Adjuvant radiotherapy for margin-positive high-grade soft tissue sarcoma of the extremity","volume":"48","author":"Alektiar","year":"2000","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/0360-3016(93)90529-5","article-title":"Outcome and prognostic factors in soft tissue sarcoma in the adult","volume":"27","author":"LeVay","year":"1993","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1001\/archoto.2011.147","article-title":"Leiomyosarcoma of the head and neck: a population-based analysis","volume":"137","author":"Eppsteiner","year":"2011","journal-title":"Arch Otolaryngol Head Neck Surg"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1002\/hed.25054","article-title":"Leiomyosarcoma of the head and neck: A 17-year single institution experience and review of the National Cancer Data Base","volume":"40","author":"Workman","year":"2018","journal-title":"Head Neck"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdt126","article-title":"Head and neck soft tissue sarcomas: prognostic factors and outcome in a series of patients treated at a single institution","volume":"24","author":"Mattavelli","year":"2013","journal-title":"Ann Oncol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.3346\/jkms.2003.18.3.355","article-title":"Pararenal leiomyosarcoma of the inferior vena cava","volume":"18","author":"Kwon","year":"2003","journal-title":"J Korean Med Sci"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1001\/jamasurg.2015.4205","article-title":"Clinical Observations and Molecular Variables of Primary Vascular Leiomyosarcoma","volume":"151","author":"Roland","year":"2016","journal-title":"JAMA Surg"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9610(77)90289-6","article-title":"Leiomyosarcoma of artery and vein","volume":"134","author":"Stringer","year":"1977","journal-title":"Am J Surg"},{"key":"B12","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1016\/S0741-5214(95)70020-X","article-title":"Leiomyosarcoma of the subclavian artery","volume":"22","author":"Giangola","year":"1995","journal-title":"J Vasc Surg"},{"key":"B13","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1016\/S0090-4295(00)00728-7","article-title":"Leiomyosarcoma of the main renal artery treated by laparoscopic radical nephrectomy","volume":"56","author":"Gill","year":"2000","journal-title":"Urology"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.3109\/00313025.2010.523691","article-title":"Intravascular leiomyosarcoma of the brachial artery: a case report","volume":"42","author":"Sivasubramaniam","year":"2010","journal-title":"Pathology"},{"key":"B15","doi-asserted-by":"publisher","first-page":"rjz308","DOI":"10.1093\/jscr\/rjz308","article-title":"Leiomyosarcoma of the superior mesenteric artery: a case report","volume":"2019","author":"Striano","year":"2019","journal-title":"J Surg Case Rep"},{"key":"B16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s12070-011-0305-8","article-title":"Head and Neck Leiomyosarcoma","volume":"65","author":"Yadav","year":"2013","journal-title":"Indian J Otolaryngol Head Neck Surg"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1161\/01.HYP.0000077441.45309.08","article-title":"Baroreflex failure as a late sequela of neck irradiation","volume":"42","author":"Sharabi","year":"2003","journal-title":"Hypertension"},{"key":"B18","doi-asserted-by":"publisher","first-page":"890","DOI":"10.3390\/cancers5030890","article-title":"Head and neck sarcomas: a comprehensive cancer center experience","volume":"5","author":"Tejani","year":"2013","journal-title":"Cancers (Basel)"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.2016-0474","article-title":"Salvage Therapy in Advanced Adult Soft Tissue Sarcoma: A Systematic Review and Meta-Analysis of Randomized Trials","volume":"22","author":"Comandone","year":"2017","journal-title":"Oncologist"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.annonc.a058622","article-title":"Epirubicin and ifosfamide in advanced soft tissue sarcomas","volume":"4","author":"Frustaci","year":"1993","journal-title":"Ann Oncol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2020.1707","article-title":"Effect of Doxorubicin Plus Olaratumab vs Doxorubicin Plus Placebo on Survival in Patients With Advanced Soft Tissue Sarcomas: The ANNOUNCE Randomized Clinical Trial","volume":"323","author":"Tap","year":"2020","journal-title":"JAMA"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2020.599403\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,13]],"date-time":"2021-02-13T16:36:05Z","timestamp":1613234165000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2020.599403\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,11]]},"references-count":21,"alternative-id":["10.3389\/fonc.2020.599403"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2020.599403","relation":{},"ISSN":["2234-943X"],"issn-type":[{"type":"electronic","value":"2234-943X"}],"subject":[],"published":{"date-parts":[[2021,2,11]]},"article-number":"599403"}}